6O24 image
Deposition Date 2019-02-22
Release Date 2020-07-01
Last Version Date 2024-10-23
Entry Detail
PDB ID:
6O24
Keywords:
Title:
Crystal structure of 4498 Fab in complex with circumsporozoite protein NANP3 and anti-Kappa VHH domain
Biological Source:
Source Organism:
Homo sapiens (Taxon ID: 9606)
Lama glama (Taxon ID: 9844)
Plasmodium falciparum (Taxon ID: 5833)
Host Organism:
Method Details:
Experimental Method:
Resolution:
1.40 Å
R-Value Free:
0.18
R-Value Work:
0.16
R-Value Observed:
0.16
Space Group:
P 1 21 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:4498 Fab heavy chain
Chain IDs:A
Chain Length:230
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:4498 Kappa light chain
Chain IDs:B
Chain Length:213
Number of Molecules:1
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Molecule:Circumsporozoite protein
Chain IDs:D (auth: I)
Chain Length:12
Number of Molecules:1
Biological Source:Plasmodium falciparum
Polymer Type:polypeptide(L)
Molecule:Anti-kappa VHH domain
Chain IDs:C (auth: K)
Chain Length:121
Number of Molecules:1
Biological Source:Lama glama
Primary Citation
Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs.
Nat. Med. 26 1135 1145 (2020)
PMID: 32451496 DOI: 10.1038/s41591-020-0881-9

Abstact

The circumsporozoite protein of the human malaria parasite Plasmodium falciparum (PfCSP) is the main target of antibodies that prevent the infection and disease, as shown in animal models. However, the limited efficacy of the PfCSP-based vaccine RTS,S calls for a better understanding of the mechanisms driving the development of the most potent human PfCSP antibodies and identification of their target epitopes. By characterizing 200 human monoclonal PfCSP antibodies induced by sporozoite immunization, we establish that the most potent antibodies bind around a conserved (N/D)PNANPN(V/A) core. High antibody affinity to the core correlates with protection from parasitemia in mice and evolves around the recognition of NANP motifs. The data suggest that the rational design of a next-generation PfCSP vaccine that elicits high-affinity antibody responses against the core epitope will promote the induction of protective humoral immune responses.

Legend

Protein

Chemical

Disease

Primary Citation of related structures